The First Lung Cancer Vaccine Enters Clinical Trial Phase in Seven Countries
Lung cancer is one of the leading causes of mortality worldwide, with an estimated 1.8 million deaths annually, according to the World Health Organization (WHO). Currently, the development of an effective vaccine against this type of cancer is considered one of the greatest advancements in oncology. Recently, the first messenger RNA (mRNA) vaccine for lung cancer has entered clinical trials, generating significant anticipation in the scientific…